Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GSSSI
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Enoblituzumab-ADC-Tb1-25
|
|||||
| Synonyms |
Enoblituzumab ADC Tb1 25
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Enoblituzumab
|
Antibody Info | ||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Enoblituzumab-ADC-Tb1-25 linker
|
|||||